| Literature DB >> 31042325 |
Mingming Zhu1,2, Zongmei Zheng1, Jiaming Huang1, Xiao Ma2, Cong Huang2, Rui Wu2, Xiaoting Li3,2, Zhaofeng Liang2, Feifei Deng2, Jieshu Wu3,2, Shanshan Geng3,2, Chunfeng Xie3,2, Caiyun Zhong3,2.
Abstract
Curcumin is a phytochemical which exhibits significant inhibitory effect in multiple cancers including prostate cancer. MicroRNA-34a (miR-34a) was found to be a master tumor suppressor miRNA and regulated the growth of cancer cells. To date, however, the role of miR-34a in the anticancer action of curcumin against prostate cancer has been rarely reported. In the present study, we showed that curcumin altered the expression of cell cycle-related genes (cyclin D1, PCNA, and p21) and inhibited the proliferation of prostate cancer cells. Furthermore, we found that curcumin significantly upregulated the expression of miR-34a, along with the downregulated expression of β-catenin and c-myc in three prostate cancer cell lines. Inhibition of miR-34a activated β-catenin/c-myc axis, altered cell cycle-related genes expression and significantly suppressed the antiproliferation effect of curcumin in prostate cancer cells. Findings from this study revealed that miR-34a plays an important role in the antiproliferation effect of curcumin in prostate cancer.Entities:
Keywords: cell proliferation; curcumin; miR-34a; prostate cancer; β-catenin/c-myc
Year: 2019 PMID: 31042325 DOI: 10.1002/jcb.28828
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429